Arnaud Scherpereel

Arnaud Scherpereel

UNVERIFIED PROFILE

Are you Arnaud Scherpereel?   Register this Author

Register author
Arnaud Scherpereel

Arnaud Scherpereel

Publications by authors named "Arnaud Scherpereel"

Are you Arnaud Scherpereel?   Register this Author

100Publications

2068Reads

33Profile Views

Reply to K. Masuda et al.

J Clin Oncol 2019 Sep 22;37(25):2294-2295. Epub 2019 Jul 22.

Dean A. Fennell, PhD, MD, University of Leicester and University Hospitals of Leicester National Health Service Trust, Leicester, United Kingdom; Paul Taylor, MD, Wythenshawe Hospital, Manchester, United Kingdom; David Gilligan, MD, Cambridge University Hospitals National Health Service Foundation Trust, Addenbrooke's Hospital, Cambridge, United Kingdom; Takashi Nakano, MD, PhD, Hyogo College of Medicine, Nishinomiya, Japan; Arnaud Scherpereel, MD, PhD, Calmette Hospital, Regional University Hospital of Lille, Lille, France; Nick Pavlakis, MD, PhD, Northern Cancer Institute, St Leonards, NSW, Australia; Jan P. van Meerbeeck, MD, PhD, Universitair Ziekenuis, Antwerp, Belgium; Joachim G.J.V. Aerts, MD, PhD, Erasmus Medical College, Rotterdam, the Netherlands; Anna K. Nowak, MD, PhD, University of Western Australia and Sir Charles Gairdner Hospital, Perth, WA, Australia; Hedy Kindler, MD, University of Chicago Medical Center, Chicago, IL; and Paul Baas, MD, PhD, Netherlands Cancer Institute, Amsterdam, the Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.19.01208DOI Listing
September 2019

Use of Immune Checkpoint Inhibitors in Mesothelioma.

Curr Treat Options Oncol 2019 Feb 14;20(2):18. Epub 2019 Feb 14.

Department of Thoracic/Head and Neck Medical Oncology, University of Texas M.D. Anderson Cancer Center, 1515 Holcombe Blvd. Unit 432, Houston, TX, 77030, USA.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s11864-019-0613-x
Publisher Site
http://dx.doi.org/10.1007/s11864-019-0613-xDOI Listing
February 2019

Compliance and Outcome of Elderly Patients Treated in the Concurrent Once-Daily Versus Twice-Daily Radiotherapy (CONVERT) Trial.

J Thorac Oncol 2019 Jan 31;14(1):63-71. Epub 2018 Oct 31.

Department of Radiotherapy Related Research, The Christie NHS Foundation Trust, Manchester, United Kingdom; Division of Cancer Sciences, School of Medical Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S15560864183318
Publisher Site
http://dx.doi.org/10.1016/j.jtho.2018.09.027DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6328625PMC
January 2019

Role of Immunotherapy in Small Cell Lung Cancer, Thymic Epithelial Tumors, and Mesothelioma.

Am Soc Clin Oncol Educ Book 2019 Jan 17;39:543-552. Epub 2019 May 17.

4 Division of Oncology, Department of Medicine, Stanford University School of Medicine and Stanford Cancer Institute, Stanford, CA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/EDBK_237847DOI Listing
January 2019

Scientific Advances and New Frontiers in Mesothelioma Therapeutics.

J Thorac Oncol 2018 09;13(9):1269-1283

Thoracic and Gastrointestinal Malignancies Branch, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jtho.2018.06.011DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6643278PMC
September 2018

Determinants of malignant pleural mesothelioma survival and burden of disease in France: a national cohort analysis.

Cancer Med 2018 04 26;7(4):1102-1109. Epub 2018 Feb 26.

Inserm U955, Institut Santé Travail Paris Est, Service de Pneumologie et de Pathologie Professionnelle, CHI Créteil, Créteil, France.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/cam4.1378
Publisher Site
http://dx.doi.org/10.1002/cam4.1378DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5911629PMC
April 2018

Novel therapies for malignant pleural mesothelioma.

Lancet Oncol 2018 03;19(3):e161-e172

Pulmonary and Thoracic Oncology Department, University of Lille, Centre Hospitalier Universitaire de Lille, Institut Pasteur de Lille, Lille, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S1470-2045(18)30100-1DOI Listing
March 2018

Immunotherapy in relapsed mesothelioma.

Immunotherapy 2018 02;10(2):77-80

Pulmonary & Thoracic Oncology, Univ Lille, CHU Lille, INSERM U1019, CIIL, Institut Pasteur de Lille, F59000 Lille, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/imt-2017-0144DOI Listing
February 2018

Real-life feasibility of home-based pulmonary rehabilitation in chemotherapy-treated patients with thoracic cancers: a pilot study.

BMC Cancer 2018 02 13;18(1):178. Epub 2018 Feb 13.

CHU Lille, Department of Respiratory Diseases, MESOCLIN, Center for Infection and Immunity of Lille (INSERM U1019 - UMR 8204 - Pasteur Institute of Lille), University of Lille, F-59000, Lille, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s12885-018-4102-6DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5810120PMC
February 2018

Immune checkpoint therapy of mesothelioma: Pre-clinical bases and clinical evidences.

Cytokine Growth Factor Rev 2017 08 12;36:25-31. Epub 2017 Jul 12.

Medical Oncology and Immunotherapy, Center for Immuno-Oncology, University Hospital of Siena, Istituto Toscano Tumori, Siena, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cytogfr.2017.07.003DOI Listing
August 2017

Real-time light dosimetry for intra-cavity photodynamic therapy: Application for pleural mesothelioma treatment.

Photodiagnosis Photodyn Ther 2017 Jun 22;18:155-161. Epub 2017 Feb 22.

INSERM, U1189, 1, Avenue Oscar Lambret, 59037, Lille Cedex, France; Lille University Hospital, 59037 Lille Cedex, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.pdpdt.2017.02.011DOI Listing
June 2017

PD-L1 Testing for Immune Checkpoint Inhibitors in Mesothelioma: For Want of Anything Better?

J Thorac Oncol 2017 05;12(5):778-781

Department of Biopathology, National referent center MESOPATH-Base National Clinicobiologic Databasis MESOBANK Register multicenter MESONAT-Sante public cancer center of Léon Bérard, Lyon, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jtho.2017.03.018DOI Listing
May 2017

Pembrolizumab-induced pneumonitis.

ERJ Open Res 2017 Apr 2;3(2). Epub 2017 May 2.

Service de Pneumologie et Immuno-allergologie, Centre de Compétences des Maladies Pulmonaires Rares, CHU Lille, Lille, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1183/23120541.00081-2016DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5413357PMC
April 2017

Malignant pleural mesothelioma: new treatments, new hopes?

Eur Respir J 2017 03 15;49(3). Epub 2017 Mar 15.

Pulmonary and Thoracic Oncology, CHU Lille, University of Lille, Lille, France

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1183/13993003.00319-2017DOI Listing
March 2017

Inequalities in lung cancer: a world of EGFR.

Eur Respir J 2016 05 30;47(5):1502-9. Epub 2016 Mar 30.

Dept of Respiratory Medicine and Thoracic Oncology, Lyon Sud Hospital, Hospices Civils de Lyon Cancer Institute, Lyon, France EMR3738 Therapeutic Targeting in Oncology, Faculty of Medicine Lyon-Sud Charles Mérieux, Lyon 1 University, Lyon, France

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1183/13993003.01157-2015DOI Listing
May 2016

FDG PET/CT allowing detection and follow-up of tumor cell transplantation.

Ann Nucl Med 2016 Apr 17;30(3):250-4. Epub 2015 Dec 17.

CHU of Lille, Department of Nuclear Medicine, Hôpital Claude Huriez, 2 Avenue Oscar Lambret, 59000, Lille, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12149-015-1051-xDOI Listing
April 2016

[Asbestos and respiratory diseases].

Presse Med 2016 Jan 26;45(1):117-32. Epub 2016 Jan 26.

CHU de Lille, institut Pasteur de Lille, université de Lille, pneumologie et oncologie thoracique, CIIL, Inserm U1019, 59000 Lille, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lpm.2015.12.011DOI Listing
January 2016

VAC chemotherapy with valproic acid for refractory/relapsing small cell lung cancer: a phase II study.

ERJ Open Res 2015 Oct 19;1(2). Epub 2015 Oct 19.

Department of Intensive Care Unit and Thoracic Oncology, Institut Jules Bordet, Centre des Tumeurs de l'Université Libre de Bruxelles (ULB), Brussels, Belgium.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1183/23120541.00029-2015DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5005117PMC
October 2015

Imaging Tumor Response and Tumoral Heterogeneity in Non-Small Cell Lung Cancer Treated With Antiangiogenic Therapy: Comparison of the Prognostic Ability of RECIST 1.1, an Alternate Method (Crabb), and Image Heterogeneity Analysis.

J Thorac Imaging 2015 Sep;30(5):300-7

*Division of Imaging Sciences and Biomedical Engineering, King's College London Departments of #Clinical Oncology **Radiology, Guy's & St Thomas' NHS Foundation Trust, London ¶Statsconsultancy Ltd, Buckinghamshire, United Kingdom †Department of Radiation Oncology, National Cancer Centre, Singapore, Singapore ‡Department of Thoracic Imaging, Hospital Calmette §Faculty of Medicine, Henri Warembourg ∥Department of Pulmonary and Thoracic Oncology, University of Lille Nord de France, Lille, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/RTI.0000000000000164DOI Listing
September 2015

Intrapleural Photodynamic Therapy for Mesothelioma: What Place and Which Future?

Ann Thorac Surg 2015 Jun 23;99(6):2237-45. Epub 2015 Apr 23.

INSERM U703, Loos, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.athoracsur.2014.12.077DOI Listing
June 2015

Higher predictive value of tumour and node [18F]-FDG PET metabolic volume and TLG in advanced lung cancer under chemotherapy.

Nucl Med Commun 2014 Sep;35(9):908-15

Departments of aNuclear Medicine bPneumology and Thoracic Oncology, CHRU Lille, Lille cFaculty of Medicine H. Warembourg, Lille North of France University, Lille, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MNM.0000000000000145DOI Listing
September 2014

Reply to B.M. Strebel.

J Clin Oncol 2014 Feb 30;32(5):479-80. Epub 2013 Dec 30.

Aix-Marseille Université, Assistance Publique Hôpitaux de Marseille; Centre Investigation Clinique, Marseille, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2013.53.7175DOI Listing
February 2014

An ELCWP phase III trial comparing ifosfamide and cisplatin regimens in advanced NSCLC.

Anticancer Res 2013 Dec;33(12):5477-82

Institut Jules Bordet, Rue Héger-Bordet, 1, B-1000 Brussels, Belgium.

View Article

Download full-text PDF

Source
December 2013

Relevance of an extensive follow-up after surgery for nonsmall cell lung cancer.

Eur Respir J 2013 Nov 21;42(5):1357-64. Epub 2013 Mar 21.

Lille University Hospital (CHRU), Lille.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1183/09031936.00086712DOI Listing
November 2013

Health-related quality of life in patients with advanced nonsquamous non-small-cell lung cancer receiving bevacizumab or bevacizumab-plus-pemetrexed maintenance therapy in AVAPERL (MO22089).

J Thorac Oncol 2013 Nov;8(11):1409-16

*Department of Thoracic Oncology, Lungenfachklinik Immenhausen, Immenhausen, Germany; †N.N. Blokhin Cancer Research Center of Russia, Moscow, Russia; ‡Department of Pulmonary Medicine, Lungkliniken, Linköping, Sweden; §Pulmonary and Thoracic Oncology Department, Hôpital Albert Calmette, CHRU de Lille, Lille, France; ‖Department of Medical Oncology, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Korea; ¶Department of Hematology and Oncology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea; #Department of Cardio-Thoracic Medicine, University of Pisa, Pisa, Italy; **Service de Pneumologie, Assistance Publique - Hopitaux de Paris, Hôpital Saint-Antoine, Paris, France; ††Global Medical Affairs, Genentech, Inc., South San Francisco, California; and ‡‡Service d' Oncologie Multidisciplinaire & Innovations Thérapeutiques, Aix Marseille University, Assistance Publique Hopitaux de Marseille, INSERM CIC, Multidisciplinary Oncology and Therapeutic Innovations, Marseille, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/JTO.0b013e3182a46bcfDOI Listing
November 2013

M14K and M38K malignant pleural mesothelioma cell lines preserve the same claudin-based phenotype in vivo.

In Vivo 2013 Mar-Apr;27(2):227-32

Department of Biology, Kouba High School, Algiers, Algeria.

View Article

Download full-text PDF

Source
August 2013

Perfusion CT allows prediction of therapy response in non-small cell lung cancer treated with conventional and anti-angiogenic chemotherapy.

Eur Radiol 2013 Aug 4;23(8):2127-36. Epub 2013 Apr 4.

Department of Thoracic Imaging, Hospital Calmette (EA 2694), University of Lille Nord de France, 59000, Lille, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00330-013-2821-2DOI Listing
August 2013

Identification of a 14 kDa endocan fragment generated by cathepsin G, a novel circulating biomarker in patients with sepsis.

J Pharm Biomed Anal 2013 May 9;78-79:45-51. Epub 2013 Feb 9.

Institut Pasteur de Lille, Center for Infection and Immunity of Lille, F-59019 Lille, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jpba.2013.01.035DOI Listing
May 2013

Lower serum endocan levels are associated with the development of acute lung injury after major trauma.

J Crit Care 2012 Oct 29;27(5):522.e11-7. Epub 2011 Sep 29.

Pulmonary, Allergy, and Critical Care Division, Department of Medicine, University of Pennsylvania School of Medicine, Philadelphia, PA 19104, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jcrc.2011.07.077DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3790584PMC
October 2012

CCL2, galectin-3, and SMRP combination improves the diagnosis of mesothelioma in pleural effusions.

J Thorac Oncol 2012 May;7(5):883-9

INSERM, U892, Institut de Recherche Thérapeutique Université de Nantes, Centre de Recherche en Cancérologie Nantes-Angers, Nantes, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/JTO.0b013e31824c9272DOI Listing
May 2012

Chemotherapy and radiotherapy for mesothelioma.

Recent Results Cancer Res 2011 ;189:127-47

Service de Pneumologie et d'Oncologie Thoracique, Hôpital Calmette, Lille Cedex, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/978-3-642-10862-4_8DOI Listing
June 2011

Malignant pleural mesothelioma: the standard of care and challenges for future management.

Crit Rev Oncol Hematol 2011 May 13;78(2):92-111. Epub 2010 May 13.

Long Oncologisch Netwerk Gent (LONG), Department of Respiratory Medicine, Ghent University Hospital, De Pintelaan 185, 9000 Gent, Belgium.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.critrevonc.2010.04.004DOI Listing
May 2011

Assessment of non-small cell lung cancer perfusion: pathologic-CT correlation in 15 patients.

Radiology 2010 Dec 15;257(3):863-71. Epub 2010 Sep 15.

Department of Thoracic Imaging and Pulmonary at Hospital Calmette, University Lille Nord de France (EA 2694 Boulevard Jules Leclercq, 59037 Lille, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1148/radiol.10100181DOI Listing
December 2010

Development of an enzyme-linked immunosorbent assay for the detection of human calretinin in plasma and serum of mesothelioma patients.

BMC Cancer 2010 May 28;10:242. Epub 2010 May 28.

Institute for Prevention and Occupational Medicine, German Social Accident Insurance, Ruhr-University Bochum (IPA), Bürkle-de-la-Camp-Platz 1, 44789 Bochum, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/1471-2407-10-242DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2886046PMC
May 2010

Serum mesothelin has a higher diagnostic utility than hyaluronic acid in malignant mesothelioma.

Clin Biochem 2009 Jul 18;42(10-11):1046-50. Epub 2009 Mar 18.

INSERM Unit 774, Institut Pasteur de Lille, Rue du Professeur Calmette, 59000 Lille, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clinbiochem.2009.03.007DOI Listing
July 2009

[Malignant mesothelioma].

Rev Prat 2009 Jun;59(6):751-5

Service de pneumologie et oncologie thoracique, hôpital Calmette, CHRU de Lille, Faculté de médecine Henri-Warembourg, université de Lille-II, unité Inserm 774, Lille.

View Article

Download full-text PDF

Source
June 2009

Screening for malignant mesothelioma--looking for the holy grail.

Am J Respir Crit Care Med 2009 May;179(9):851; author reply 851-852

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1164/ajrccm.179.9.851aDOI Listing
May 2009

Mitomycin plus vinorelbine salvage chemotherapy in non-small cell lung cancer: a prospective study.

Lung Cancer 2008 Sep 3;61(3):378-84. Epub 2008 Mar 3.

Department of Intensive Care Unit and Thoracic Oncology, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2008.01.011DOI Listing
September 2008

Aberrant splicing and protease involvement in mesothelin release from epithelioid mesothelioma cells.

Cancer Sci 2008 Mar 27;99(3):590-4. Epub 2007 Dec 27.

INSERM U601, Département de Recherche en Cancérologie, Institut de Biologie/CHU, 44093 Nantes, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1349-7006.2007.00715.xDOI Listing
March 2008

[New diagnostic markers for malignant pleural mesothelioma].

Bull Cancer 2008 Feb;95(2):177-84

Inserm U774, Institut Pasteur, Lille, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1684/bdc.2008.0576DOI Listing
February 2008

Accuracy of pleural biopsy using thoracoscopy for the diagnosis of histologic subtype in patients with malignant pleural mesothelioma.

Cancer 2007 Nov;110(10):2248-52

Division of Thoracic Oncology, Federation of Pulmonary Diseases and Thoracic Surgery, University of the Mediterranean Sea, Ste-Marguerite Hospital, Marseille, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.23034DOI Listing
November 2007

Pulmonary manifestations of Pyoderma gangrenosum.

Presse Med 2007 Oct 6;36(10 Pt 1):1395-8. Epub 2007 Jun 6.

Service de pneumologie et immuno-allergologie, Hôpital universitaire Calmette, Lille.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lpm.2007.03.031DOI Listing
October 2007

Biomarkers for mesothelioma.

Curr Opin Pulm Med 2007 Jul;13(4):339-443

Pulmonary and Thoracic Oncology Department, Hopital Calmette, Lille, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MCP.0b013e32812144bbDOI Listing
July 2007

Guidelines of the French Speaking Society for Chest Medicine for management of malignant pleural mesothelioma.

Respir Med 2007 Jun 29;101(6):1265-76. Epub 2006 Nov 29.

INSERM Unit 774, Institut Pasteur de Lille, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.rmed.2006.10.018DOI Listing
June 2007

Utility of osteopontin and serum mesothelin in malignant pleural mesothelioma diagnosis and prognosis assessment.

Clin Cancer Res 2007 May;13(10):2928-35

Institut National de la Sante et de la Recherche Medicale (INSERM) U774, Institut Pasteur de Lille, Lille, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-06-2144DOI Listing
May 2007

Factors modulating the delivery and effect of enzymatic cargo conjugated with antibodies targeted to the pulmonary endothelium.

J Control Release 2007 Apr 8;118(2):235-44. Epub 2007 Jan 8.

Institute for Environmental Medicine, School of Medicine, University of Pennsylvania Medical Center, 36th Street and Hamilron Walk, Philadelphia, PA 19104, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jconrel.2006.12.025DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1855632PMC
April 2007

Haemothorax after pig-tail catheter removal in a patient with primary spontaneous pneumothorax.

Emerg Med J 2007 Mar;24(3):e17

Clinique des Maladies Respiratoires, Hôpital Albert Calmette, Centre Hospitalier Régional Universitaire de Lille, 59037 Lille Cedex1, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/emj.2006.042465DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2660056PMC
March 2007

Dissociation between alveolar transmigration of neutrophils and lung injury in hyperoxia.

Am J Physiol Lung Cell Mol Physiol 2006 Nov 30;291(5):L1050-8. Epub 2006 Jun 30.

School of Veterinary Medicine, University of Pennsylvania, 421 Curie Blvd., BRB II/III, Philadelphia, 19104, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1152/ajplung.00067.2006DOI Listing
November 2006

Soluble mesothelin-related peptides in the diagnosis of malignant pleural mesothelioma.

Am J Respir Crit Care Med 2006 May 2;173(10):1155-60. Epub 2006 Feb 2.

INSERM Unit 774, Institut Pasteur de Lille, 59037 Lille Cedex, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1164/rccm.200511-1789OCDOI Listing
May 2006

[Quincke's edema and anaphylaxis].

Rev Prat 2003 Jun;53(11):1245-51

Service de pneumo-immuno-allergologie, hôpital Calmette, CHRU de Lille, 59037 Lille.

View Article

Download full-text PDF

Source
June 2003